Health Care Should Go (Micro) Nuclear

By KIM BELLARD I think of hospitals as the healthcare system’s nuclear power plants.  They’re both big, complex, expensive to build, beset with heavy regulatory burdens, consistently major components of their respective systems (healthcare and electric generation) yet declining in number.  Each is seen to offer benefits to many but also to pose unexpected risk… Read More »

Increase of Certain Fatty Acids Can Help Reduce Migraine Severity

Migraine is among the biggest reasons for disability worldwide. Current treatment options are sometimes inadequate for providing complete relief for sufferers. Research has found that a change in diet provides one more option sufferers are able to use in their attempt to have less headaches and migraines.1✅ JOURNAL REFERENCEDOI: 10.1136/bmj.n1448 Polyunsaturated fatty acids, which the… Read More »

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

CDC: Delta variant accounts for 83% of US cases

NEW YORK – Health officials say the Delta variant of the coronavirus continues to surge and accounts for an estimated 83% of U.S. COVID-19 cases. That’s a dramatic increase from the week of July 3, when the variant accounted for about 50% of genetically sequenced coronavirus cases. Dr. Anthony Fauci, director of the National Institute… Read More »